U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H24N4O4
Molecular Weight 420.4611
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BRENSOCATIB

SMILES

CN1C(=O)OC2=CC=C(C=C12)C3=CC=C(C[C@H](NC(=O)[C@@H]4CNCCCO4)C#N)C=C3

InChI

InChIKey=AEXFXNFMSAAELR-RXVVDRJESA-N
InChI=1S/C23H24N4O4/c1-27-19-12-17(7-8-20(19)31-23(27)29)16-5-3-15(4-6-16)11-18(13-24)26-22(28)21-14-25-9-2-10-30-21/h3-8,12,18,21,25H,2,9-11,14H2,1H3,(H,26,28)/t18-,21-/m0/s1

HIDE SMILES / InChI

Molecular Formula C23H24N4O4
Molecular Weight 420.4611
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 13:19:38 UTC 2023
Edited
by admin
on Sat Dec 16 13:19:38 UTC 2023
Record UNII
25CG88L0BB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD-7986
Preferred Name English
BRENSOCATIB
USAN   INN  
Official Name English
brensocatib [INN]
Common Name English
AZD7986
Code English
1,4-OXAZEPINE-2-CARBOXAMIDE, N-((1S)-1-CYANO-2-(4-(2,3-DIHYDRO-3-METHYL-2-OXO-5-BENZOXAZOLYL)PHENYL)ETHYL)HEXAHYDRO-, (2S)-
Systematic Name English
BRENSOCATIB [USAN]
Common Name English
Brensocatib [WHO-DD]
Common Name English
INS1007
Code English
INS-1007
Code English
(S)-N-((S)-1-CYANO-2-(4-(3-METHYL-2-OXO-2,3-DIHYDROBENZO-(D)OXAZOL-5-YL)PHENYL)ETHYL)-1,4-OXAZEPANE-2-CARBOXAMIDE
Systematic Name English
Code System Code Type Description
FDA UNII
25CG88L0BB
Created by admin on Sat Dec 16 13:19:38 UTC 2023 , Edited by admin on Sat Dec 16 13:19:38 UTC 2023
PRIMARY
INN
11097
Created by admin on Sat Dec 16 13:19:38 UTC 2023 , Edited by admin on Sat Dec 16 13:19:38 UTC 2023
PRIMARY
CAS
1802148-05-5
Created by admin on Sat Dec 16 13:19:38 UTC 2023 , Edited by admin on Sat Dec 16 13:19:38 UTC 2023
PRIMARY
DRUG BANK
DB15638
Created by admin on Sat Dec 16 13:19:38 UTC 2023 , Edited by admin on Sat Dec 16 13:19:38 UTC 2023
PRIMARY
PUBCHEM
118253852
Created by admin on Sat Dec 16 13:19:38 UTC 2023 , Edited by admin on Sat Dec 16 13:19:38 UTC 2023
PRIMARY
SMS_ID
300000010203
Created by admin on Sat Dec 16 13:19:38 UTC 2023 , Edited by admin on Sat Dec 16 13:19:38 UTC 2023
PRIMARY
USAN
JK-48
Created by admin on Sat Dec 16 13:19:38 UTC 2023 , Edited by admin on Sat Dec 16 13:19:38 UTC 2023
PRIMARY
NCI_THESAURUS
C171778
Created by admin on Sat Dec 16 13:19:38 UTC 2023 , Edited by admin on Sat Dec 16 13:19:38 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
Information). The interaction could be described with a simple 1:1 interaction model resulting in an on-rate (kon) and an ;-rate (koff) of 4.0 ? 0−3 ;1, giving a pKd value of 8.6. The residence time at the DPP1 enzyme, by half-life, was 3 min.
INHIBITOR
Ki
TARGET -> INHIBITOR
in Vitro Using Differentiating Human Primary Bone Marrow-Derived CD34+ Neutrophil Progenitor Cells
INHIBITOR
IC50
Related Record Type Details
ACTIVE MOIETY